OCEA Ocean Biomedical: Narxning prognoz qilingan daromadga nisbati
Ocean Biomedical, Inc. (OCEA) FDA patentlari va Brown University litsenziyalari orqali biznes barqarorligini saqlab qolmoqda. GURU.Markets platformasidagi prognoz qilingan sotuvlarga nisbatan narx koeffitsiyenti baholash tendentsiyasini aks ettiradi, bunda eng so'nggi metrika ko'rsatkichini ifodalaydi. Kompaniya saraton va bezgakka qarshi kurashish uchun yopiq konturli antitanalar tizimiga tayanadi va ilmiy kashfiyotlarini tijoratlashtirish tizimi orqali yetakchi tadqiqotchilarni jalb qilmoqda.
Ocean Biomedical Corp (OCEA) kompaniyasi koʻrsatkichlari kesimi va tahlili
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Ocean Biomedical, Inc.|OCEA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Ocean Biomedical, Inc.|OCEA - Kompaniyaning jamlangan qarzi|Qarzning balans qiymatiga nisbati Ocean Biomedical Corp|OCEA - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzlari Ocean Biomedical|Tezkor likvidlik koeffitsiyenti oceanbiomedical.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
OCEA - Sof moliyaviy natija|Kutilayotgan foyda Ocean Biomedical, Inc.|OCEA - Kapitalizatsiyaning foydaga nisbati|Kelajakdagi narxning foydaga nisbati Ocean Bio|OCEA - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori Ocean Biomedical Corp|OCEA - Foizlar, soliqlar va eskirishdan oldingi foyda|Bir aksiya uchun sof foyda (EPS TTM) Ocean Biomedical|OCEA - So'nggi 12 oy davomida bir aksiya uchun foyda|Choraklik EPS foyda o'sishi oceanbiomedical.com|OCEA - Bu yil bir aksiya uchun sof foydaning kutilayotgan o'sishi|Keyingi yil uchun foyda o'sishi prognozi Ocean Biomedical, Inc.
- sotuvlar va tushum bo'yicha ma'lumotlar:
Kompaniyaning fundamental baholanishi:Ocean Biomedical (OCEA)
Uzoq muddatli portfelni shakllantirishda, aktivning haddan tashqari qimmat baholanganlik darajasini aniqlash uchun bozor kapitalizatsiyasini kutilayotgan daromadlar bilan bog'lash juda muhimdir. Forward P/S koeffitsiyenti kompaniya qiymatini prognoz qilingan savdo hajmlariga nisbatan o'lchaydi, bu esa ushbu grafikdagi narx momentumini kuzatish orqali B2B sherikliklarini kengaytirish yo'li bilan Ocean Biomedical, Inc. (OCEA) kompaniyasining onkologiya sohasidagi kengayish salohiyatini baholash imkonini beradi.
Muhim raqobatchilar
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|ABVX - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati ADMA Corp|PTGX: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori immunovant.com|KNSA (Kiniksa) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Grifols SA GRFS|Forvard P/S multiplikatori ADPT|Forvard P/S multiplikatori Celldex Corp (CLDX)|Narxning prognoz qilingan daromadga nisbati Aurinia Pharmaceuticals AUPH|BCRX: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|VERA: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx DNTH (Dianthus Therapeutics Inc)|PHVS: Forvard P/S multiplikatori|ABCL (AbCellera Corp) - Narxning prognoz qilingan daromadga nisbati|TRML (Tourmaline Bio, Inc.) - Forvard P/S multiplikatori|precigen.com (PGEN) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Pharming Group (PHAR)|NKTR - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Upstream Bio Corp UPB|ZBIO - Forvard narx/daromad multiplikatori|Immunome, Inc. - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati gossamerbio.com|KALV: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati SEPN|PVLA (Pieris Pharmaceuticals Inc) - Forvard P/S multiplikatori|Savara Pharma (SVRA) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori RIGL|Forvard narx/daromad multiplikatori anaptysbio.com ANAB|Forvard P/S multiplikatori ATXS (Astria Therapeutics, Inc.)|Forvard P/S multiplikatori enGene Holdings Inc ENGN|RAPT - Narxning prognoz qilingan daromadga nisbati|JBIO: Narxning prognoz qilingan daromadga nisbati|ACRS (Aclaris Therapeutics) - Forvard narx/daromad multiplikatori|kyvernatx.com - Sotuvga nisbatan forvard narx|TLSA (Tiziana Life Sciences Ltd) - Forvard P/S multiplikatori|Cabaletta Bio Inc. (CABA) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Ventyx Bio (VTYX)|Theratechnologies, Inc - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori AVTX (Avalo Therapeutics, Inc)|ELDN - Forvard narx/daromad multiplikatori|AGEN: Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Climb Bio Inc. CLYM|Zura Bio Limited (ZURA) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati aTyr Pharmaceuticals (ATYR)|ADAG (Adagene Inc) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Ikena Oncology, Inc. (IMA)|Forvard P/S multiplikatori STTK|EQ - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori CNTB (Connect Biopharma Holdings Limited)|Forvard P/S multiplikatori Immunic Therapeutics IMUX|ATRA - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati IFRX|XFOR: Forvard P/S multiplikatori|Adicet Bio, Inc. - Sotuvga nisbatan forvard narx|CELU (Celularity Inc) - Forvard P/S multiplikatori|Forvard P/S multiplikatori INmune Bio Corporation|Narxning prognoz qilingan daromadga nisbati Barinthus Biotherapeutics (BRNS)|KZR (kezarlifesciences.com) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati SAB Biotherapeutics, Inc. SABS|AKTX - Forvard narx/daromad multiplikatori|Enlivex Therapeutics, Ltd. - Forvard P/S multiplikatori|QTTB - Forvard P/S multiplikatori|GOVX (GeoVax Labs, Inc.) - Forvard narx/daromad multiplikatori|edesabiotech.com - Sotuvga nisbatan forvard narx|IBIO (iBio) - Forvard P/S multiplikatori|Carisma Tx (CARM) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati XTL Biopharmaceuticals, Ltd. (XTLB)|Forvard narx/daromad multiplikatori boltbio.com BOLT|Narxning prognoz qilingan daromadga nisbati HCW Biologics HCWB|APVO - Forvard narx/daromad multiplikatori|AIM: Forvard narx/daromad multiplikatori|ADTX - Forvard P/S multiplikatori|GRI Bio Corp (GRI) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati XRTX|HIND (Vyome Holdings Inc) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati revbiosciences.com REVB|Narxning prognoz qilingan daromadga nisbati Indaptus Therapeutics, Inc. (INDP)|SCNI - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Forvard P/S multiplikatori CALI (CalciMedica)|AFMD - Forvard narx/daromad multiplikatori|Allakos Therapeutics - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati HOOKIPA Pharma Inc.|IGMS: Forvard P/S multiplikatori|iTeos Therapeutics Inc (ITOS) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati TC BioPharm (Holdings) PLC|Kapitalizatsiyaning prognoz qilingan daromadga nisbati THRD (Third Harmonic Bio Inc)
